机构：[1]HEBEI TUMOR HOSP,DEPT RADIOTHERAPY,SHIJIAZHUANG 050011,PEOPLES R CHINA河北医科大学第四医院
出处：
ISSN：
摘要：
Between February 1989 and May 1983, 172 patients with esophageal carcinoma were given radiotherapy. They were randomly assigned to an accelerated hyperfractionation group and routine fractionation group. There was no statistically significant length of survival difference between these two groups at 1, 3 and 5 years. Therefore accelerated hyperfractionation is useful for its economy of duration and cost.
第一作者机构：[1]HEBEI TUMOR HOSP,DEPT RADIOTHERAPY,SHIJIAZHUANG 050011,PEOPLES R CHINA
通讯作者：
通讯机构：[1]HEBEI TUMOR HOSP,DEPT RADIOTHERAPY,SHIJIAZHUANG 050011,PEOPLES R CHINA
推荐引用方式(GB/T 7714)：
WAN J,GUO BZ,GAO SZ.ACCELERATED HYPERFRACTIONATION RADIOTHERAPY IN ESOPHAGEAL CANCER - AN ANALYSIS OF 172 CASES[J].CHINESE MEDICAL JOURNAL.1991,104(3):228-229.
APA：
WAN, J,GUO, BZ&GAO, SZ.(1991).ACCELERATED HYPERFRACTIONATION RADIOTHERAPY IN ESOPHAGEAL CANCER - AN ANALYSIS OF 172 CASES.CHINESE MEDICAL JOURNAL,104,(3)
MLA：
WAN, J,et al."ACCELERATED HYPERFRACTIONATION RADIOTHERAPY IN ESOPHAGEAL CANCER - AN ANALYSIS OF 172 CASES".CHINESE MEDICAL JOURNAL 104..3(1991):228-229
